{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:49:51Z","timestamp":1790596191270,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s00436-022-07753-8","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T04:31:55Z","timestamp":1670905915000},"page":"519-526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["High prevalence of persistent residual parasitemia on days 3 and 14 after artemether\u2013lumefantrine or pyronaridine\u2013artesunate treatment of uncomplicated Plasmodium falciparum malaria in Nigeria"],"prefix":"10.1007","volume":"122","author":[{"given":"Roland I.","family":"Funwei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel N.","family":"Uyaiabasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasiu A.","family":"Hammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olusola","family":"Ojurongbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oladapo","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine O.","family":"Falade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"7753_CR1","doi-asserted-by":"publisher","unstructured":"Amambua-Ngwa A, Okebe J, Mbye H, Ceesay S, El-Fatouri F, Joof F, Nyang H, Janha R, Affara M, Ahmad A, Kolly O, Nwakanma D, D'Alessandro U (2017) Sustained ex vivosusceptibility of Plasmodium falciparum toartemisinin derivatives but increasing toleranceto artemisinin combination therapy partnerquinolines in The Gambia. Antimicrob Agents Chemother 61:e00759-17. https:\/\/doi.org\/10.1128\/AAC.00759-17","DOI":"10.1128\/AAC.00759-17"},{"key":"7753_CR2","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","volume":"385","author":"B Balikagala","year":"2021","unstructured":"Balikagala B, Fukuda N, Ikeda M, Katuro OT, Tachibana S-I, Yamauchi M, Opio W, Emoto S, Anywar DA, Kimura E et al (2021) Evidence of artemisinin-resistant malaria in Africa. N Engl J Med 385:1163\u20131171. https:\/\/doi.org\/10.1056\/NEJMoa2101746","journal-title":"N Engl J Med"},{"key":"7753_CR3","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3201\/eid2701.203527","volume":"27","author":"C Bergmann","year":"2021","unstructured":"Bergmann C, van Loon W, Habarugira F, Tacoli C, J\u00e4ger JC, Savelsberg D, Nshimiyimana F, Rwamugema E, Mbarushimana D, Ndoli J et al (2021) Increase in Kelch 13 polymorphisms in Plasmodium falciparum, Southern Rwanda. Emerg Infect Dis 27:294. https:\/\/doi.org\/10.3201\/eid2701.203527","journal-title":"Emerg Infect Dis"},{"key":"7753_CR4","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1093\/infdis\/jit431","volume":"208","author":"KB Beshir","year":"2013","unstructured":"Beshir KB, Sutherland CJ, Sawa P, Drakeley CJ, Okell L, Mweresa CK, Omar SA, Shekalaghe SA, Kaur H, Ndaro A et al (2013) Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence. J Infect Dis 208:2017\u20132024. https:\/\/doi.org\/10.1093\/infdis\/jit431","journal-title":"J Infect Dis"},{"key":"7753_CR5","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s12936-018-2552-6","volume":"17","author":"P Byakika-Kibwika","year":"2018","unstructured":"Byakika-Kibwika P, Nyakato P, Lamorde M, Kiragga AN (2018) Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial. Malar J 17:400. https:\/\/doi.org\/10.1186\/s12936-018-2552-6","journal-title":"Malar J"},{"key":"7753_CR6","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/1475-2875-10-380","volume":"10","author":"AM Carlsson","year":"2011","unstructured":"Carlsson AM, Ngasala BE, Dahlstr\u00f6m S, Membi C, Veiga IM, Rombo L, Abdulla S, Premji Z, Gil JP, Bj\u00f6rkman A et al (2011) Plasmodium falciparum population dynamics during the early phase of anti-malarial drug treatment in Tanzanian children with acute uncomplicated malaria. Malar J 10:380. https:\/\/doi.org\/10.1186\/1475-2875-10-380","journal-title":"Malar J"},{"key":"7753_CR7","doi-asserted-by":"publisher","first-page":"26330","DOI":"10.1038\/srep26330","volume":"6","author":"H-H Chang","year":"2016","unstructured":"Chang H-H, Meibalan E, Zelin J, Daniels R, Eziefula AC, Meyer EC, Tadesse F, Grignard L, Joice RC, Drakeley C et al (2016) Persistence of Plasmodium falciparum parasitemia after artemisinin combination therapy: evidence from a randomized trial in Uganda. Sci Rep 6:26330. https:\/\/doi.org\/10.1038\/srep26330","journal-title":"Sci Rep"},{"key":"7753_CR8","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12936-020-03352-z","volume":"19","author":"M Dhorda","year":"2020","unstructured":"Dhorda M, Ba EH, Kevin Baird J, Barnwell J, Bell D, Carter JY, Dondorp A, Ekawati L, Gatton M, Gonz\u00e1lez I et al (2020) Towards harmonization of microscopy methods for malaria clinical research studies. Malar J 19:324. https:\/\/doi.org\/10.1186\/s12936-020-03352-z","journal-title":"Malar J"},{"key":"7753_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12936-018-2389-z","volume":"17","author":"G Froeschl","year":"2018","unstructured":"Froeschl G, Saathoff E, Kroidl I, Berens-Riha N, Clowes P, Maboko L, Assisya W, Mwalongo W, Gerhardt M, Ntinginya EN et al (2018) Reduction of malaria prevalence after introduction of artemisinin-combination-therapy in Mbeya Region, Tanzania: results from a cohort study with 6773 participants. Malar J 17:245. https:\/\/doi.org\/10.1186\/s12936-018-2389-z","journal-title":"Malar J"},{"key":"7753_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-017-2149-5","volume":"17","author":"RI Funwei","year":"2018","unstructured":"Funwei RI, Thomas BN, Falade CO, Ojurongbe O (2018) Extensive diversity in the allelic frequency of Plasmodium falciparum merozoite surface proteins and glutamate-rich protein in rural and urban settings of southwestern Nigeria. Malar J 17:1. https:\/\/doi.org\/10.1186\/s12936-017-2149-5","journal-title":"Malar J"},{"issue":"4","key":"7753_CR11","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1371\/journal.pmed.0020105","volume":"2","author":"P Garner","year":"2005","unstructured":"Garner P, Graves PM (2005) The benefits of artemisinin combination therapy for malaria extend beyond the individual patient. PLOS Med 2(4):e105. https:\/\/doi.org\/10.1371\/journal.pmed.0020105","journal-title":"PLOS Med"},{"key":"7753_CR12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12936-015-0775-3","volume":"14","author":"G Getnet","year":"2015","unstructured":"Getnet G, Fola AA, Alemu A, Getie S, Fuehrer H-P, Noedl H (2015) Therapeutic efficacy of artemether\u2013lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Enfranze, north-west Ethiopia. Malar J 14:258. https:\/\/doi.org\/10.1186\/s12936-015-0775-3","journal-title":"Malar J"},{"key":"7753_CR13","doi-asserted-by":"publisher","first-page":"6428","DOI":"10.1128\/AAC.00481-15","volume":"59","author":"IM Hastings","year":"2015","unstructured":"Hastings IM, Kay K, Hodel EM (2015) How robust are malaria parasite clearance rates as indicators of drug effectiveness and resistance? Antimicrob. Agents Chemother 59:6428\u20136436. https:\/\/doi.org\/10.1128\/AAC.00481-15","journal-title":"Agents Chemother"},{"key":"7753_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S1473-3099(17)30048-8","volume":"17","author":"M Imwong","year":"2017","unstructured":"Imwong M, Suwannasin K, Kunasol C, Sutawong K, Mayxay M, Rekol H, Smithuis FM, Hlaing TM, Tun KM, van der Pluijm RW et al (2017) The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study. Lancet Infect Dis 17:491\u2013497. https:\/\/doi.org\/10.1016\/S1473-3099(17)30048-8","journal-title":"Lancet Infect Dis"},{"key":"7753_CR15","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1128\/IAI.66.8.3783-3787.1998","volume":"66","author":"W Jarra","year":"1998","unstructured":"Jarra W, Snounou G (1998) Only viable parasites are detected by PCR following clearance of rodent malarial infections by drug treatment or immune responses. Infect Immun 66:3783\u20133787","journal-title":"Infect Immun"},{"key":"7753_CR16","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1186\/s12936-015-1018-3","volume":"14","author":"K Kiaco","year":"2015","unstructured":"Kiaco K, Teixeira J, Machado M, do Ros\u00e1rio V, Lopes D, (2015) Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda. Angola Malar J 14:504. https:\/\/doi.org\/10.1186\/s12936-015-1018-3","journal-title":"Angola Malar J"},{"key":"7753_CR17","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/infdis\/jit082","volume":"207","author":"TM Lopera-Mesa","year":"2013","unstructured":"Lopera-Mesa TM, Doumbia S, Chiang S, Zeituni AE, Konate DS, Doumbouya M, Keita AS, Stepniewska K, Traore K, Diakite SAS et al (2013) Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity. J Infect Dis 207:1655\u20131663. https:\/\/doi.org\/10.1093\/infdis\/jit082","journal-title":"J Infect Dis"},{"key":"7753_CR18","doi-asserted-by":"publisher","first-page":"ofaa116","DOI":"10.1093\/ofid\/ofaa116","volume":"7","author":"IND Lubis","year":"2020","unstructured":"Lubis IND, Wijaya H, Lubis M, Lubis CP, Beshir KB, Staedke SG, Sutherland CJ (2020) Recurrence of Plasmodium malariae and P. falciparum following treatment of uncomplicated malaria in North Sumatera with dihydroartemisinin-piperaquine or artemether-lumefantrine. Open Forum Infect Dis 7:ofaa116. https:\/\/doi.org\/10.1093\/ofid\/ofaa116","journal-title":"Open Forum Infect Dis"},{"key":"7753_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12936-020-03287-5","volume":"19","author":"LE Mhamilawa","year":"2020","unstructured":"Mhamilawa LE, Ngasala B, Morris U, Kitabi EN, Barnes R, Soe AP, Mmbando BP, Bj\u00f6rkman A, M\u00e5rtensson A (2020) Parasite clearance, cure rate, post-treatment prophylaxis and safety of standard 3-day versus an extended 6-day treatment of artemether\u2013lumefantrine and a single low-dose primaquine for uncomplicated Plasmodium falciparum malaria in Bagamoyo district, Tanzania: a randomized controlled trial. Malar J 19:216. https:\/\/doi.org\/10.1186\/s12936-020-03287-5","journal-title":"Malar J"},{"key":"7753_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12936-020-03235-3","volume":"19","author":"R Mwaiswelo","year":"2020","unstructured":"Mwaiswelo R, Ngasala B (2020) Evaluation of residual submicroscopic Plasmodium falciparum parasites 3 days after initiation of treatment with artemisinin-based combination therapy. Malar J 19:162. https:\/\/doi.org\/10.1186\/s12936-020-03235-3","journal-title":"Malar J"},{"key":"7753_CR21","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12936-016-1341-3","volume":"15","author":"R Mwaiswelo","year":"2016","unstructured":"Mwaiswelo R, Ngasala BE, Jovel I, Gosling R, Premji Z, Poirot E, Mmbando BP, Bj\u00f6rkman A, M\u00e5rtensson A (2016) Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania. Malar J 15:316. https:\/\/doi.org\/10.1186\/s12936-016-1341-3","journal-title":"Malar J"},{"key":"7753_CR22","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.4269\/ajtmh.18-0729","volume":"100","author":"R Mwaiswelo","year":"2019","unstructured":"Mwaiswelo R, Ngasala B, Jovel I, Xu W, Larsson E, Malmberg M, Gil JP, Premji Z, Mmbando BP, M\u00e5rtensson A (2019) Prevalence of and risk factors associated with polymerase chain reaction-determined plasmodium falciparum positivity on day 3 after initiation of artemether\u2013lumefantrine treatment for uncomplicated malaria in Bagamoyo District, Tanzania. Am J Trop Med Hyg 100:1179\u20131186. https:\/\/doi.org\/10.4269\/ajtmh.18-0729","journal-title":"Am J Trop Med Hyg"},{"key":"7753_CR23","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1086\/341938","volume":"186","author":"C Ohrt","year":"2002","unstructured":"Ohrt C, Purnomo P, Sutamihardja MA, Tang D, Kain KC (2002) Impact of microscopy error on estimates of protective efficacy in malaria-prevention trials. J Infect Dis 186:540\u2013546. https:\/\/doi.org\/10.1086\/341938","journal-title":"J Infect Dis"},{"key":"7753_CR24","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.76519","author":"AP Phyo","year":"2018","unstructured":"Phyo AP, Nosten F (2018) The artemisinin resistance in Southeast Asia: an imminent global threat to malaria elimination. Malar Elimin - Leap Forw. https:\/\/doi.org\/10.5772\/intechopen.76519","journal-title":"Malar Elimin - Leap Forw"},{"key":"7753_CR25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12936-019-2911-y","volume":"18","author":"J Raman","year":"2019","unstructured":"Raman J, Kagoro FM, Mabuza A, Malatje G, Reid A, Frean J, Barnes KI (2019) Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001\u20132018). Malar J 18:280. https:\/\/doi.org\/10.1186\/s12936-019-2911-y","journal-title":"Malar J"},{"key":"7753_CR26","doi-asserted-by":"publisher","first-page":"970","DOI":"10.4269\/ajtmh.18-0233","volume":"99","author":"JM Roth","year":"2018","unstructured":"Roth JM, Sawa P, Omweri G, Makio N, Osoti V, de Jong MD, Schallig HDFH, Mens PF (2018) Molecular detection of residual parasitemia after pyronaridine\u2013artesunate or artemether\u2013lumefantrine treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children. Am J Trop Med Hyg 99:970\u2013977. https:\/\/doi.org\/10.4269\/ajtmh.18-0233","journal-title":"Am J Trop Med Hyg"},{"key":"7753_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0166-6851(93)90077-B","volume":"61","author":"G Snounou","year":"1993","unstructured":"Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, do Rosario VE, Thaithong S, Brown KN (1993) High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol 61:315\u2013320","journal-title":"Mol Biochem Parasitol"},{"key":"7753_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40249-019-0577-x","volume":"8","author":"A Sowunmi","year":"2019","unstructured":"Sowunmi A, Ntadom G, Akano K, Ibironke FO, Ayede AI, Agomo C, Folarin OA, Gbotosho GO, Happi C, Oguche S et al (2019) Declining responsiveness of childhood Plasmodium falciparum infections to artemisinin-based combination treatments ten years following deployment as first-line antimalarials in Nigeria. Infect Dis Poverty 8:69. https:\/\/doi.org\/10.1186\/s40249-019-0577-x","journal-title":"Infect Dis Poverty"},{"key":"7753_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuaa056","author":"CJ Sutherland","year":"2020","unstructured":"Sutherland CJ, Henrici RC, Artavanis-Tsakonas K (2020) Artemisinin susceptibility in the malaria parasite Plasmodium falciparum: propellers, adaptor proteins and the need for cellular healing. FEMS Microbiol Rev. https:\/\/doi.org\/10.1093\/femsre\/fuaa056","journal-title":"FEMS Microbiol Rev"},{"key":"7753_CR30","doi-asserted-by":"publisher","first-page":"e00002","DOI":"10.1128\/aac.00002-22","volume":"0","author":"G Tadele","year":"2022","unstructured":"Tadele G, Jaiteh FK, Oboh M, Oriero E, Dugassa S, Amambua-Ngwa A, Golassa L (2022) Persistence of residual submicroscopic P. falciparum parasitemia following treatment of artemether-lumefantrine in Ethio-Sudan Border, Western Ethiopia. Antimicrob Agents Chemother 0:e00002-22. https:\/\/doi.org\/10.1128\/aac.00002-22","journal-title":"Antimicrob Agents Chemother"},{"key":"7753_CR31","doi-asserted-by":"publisher","first-page":"7049","DOI":"10.1128\/AAC.02746-14","volume":"58","author":"K Thriemer","year":"2014","unstructured":"Thriemer K, Hong NV, Rosanas-Urgell A, Phuc BQ, Ha DM, Pockele E, Guetens P, Van NV, Duong TT, Amambua-Ngwa A et al (2014) Delayed parasite clearance after treatment with dihydroartemisinin-piperaquine in Plasmodium falciparum malaria patients in Central Vietnam. Antimicrob Agents Chemother 58:7049\u20137055. https:\/\/doi.org\/10.1128\/AAC.02746-14","journal-title":"Antimicrob Agents Chemother"},{"key":"7753_CR32","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S0035-9203(02)90385-8","volume":"96","author":"E Tjitra","year":"2002","unstructured":"Tjitra E, Suprianto S, Anstey NM (2002) Higher gametocyte prevalence following failure of treatment of Plasmodium falciparum malaria with sulfadoxine-pyrimethamine and the combination of chloroquine plus sulfadoxine-pyrimethamine: implications for progression of anti-folate resistance. Trans R Soc Trop Med Hyg 96:434\u2013437. https:\/\/doi.org\/10.1016\/S0035-9203(02)90385-8","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"7753_CR33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ebiom.2017.10.003","volume":"25","author":"M Vafa Homann","year":"2017","unstructured":"Vafa Homann M, Emami SN, Yman V, Stenstr\u00f6m C, Sond\u00e9n K, Ramstr\u00f6m H, Karlsson M, Asghar M, F\u00e4rnert A (2017) Detection of malaria parasites after treatment in travelers: a 12-months longitudinal study and statistical modelling analysis. EBioMedicine 25:66\u201372. https:\/\/doi.org\/10.1016\/j.ebiom.2017.10.003","journal-title":"EBioMedicine"},{"key":"7753_CR34","doi-asserted-by":"publisher","first-page":"e1000830","DOI":"10.1371\/journal.ppat.1000830","volume":"6","author":"S Vinayak","year":"2010","unstructured":"Vinayak S, Alam MT, Mixson-Hayden T, McCollum AM, Sem R, Shah NK, Lim P, Muth S, Rogers WO, Fandeur T et al (2010) Origin and evolution of sulfadoxine resistant Plasmodium falciparum. PLOS Pathog 6:e1000830. https:\/\/doi.org\/10.1371\/journal.ppat.1000830","journal-title":"PLOS Pathog"},{"key":"7753_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12936-017-1731-1","volume":"16","author":"NJ White","year":"2017","unstructured":"White NJ (2017) Malaria parasite clearance. Malar J 16:88. https:\/\/doi.org\/10.1186\/s12936-017-1731-1","journal-title":"Malar J"},{"key":"7753_CR36","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/1475-2875-13-114","volume":"13","author":"J Zwang","year":"2014","unstructured":"Zwang J, Dorsey G, M\u00e5rtensson A, d\u2019Alessandro U, Ndiaye J-L, Karema C, Djimde A, Brasseur P, Sirima SB, Olliaro P (2014) Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999\u20132009. Malar J 13:114. https:\/\/doi.org\/10.1186\/1475-2875-13-114","journal-title":"Malar J"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-022-07753-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00436-022-07753-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-022-07753-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T05:11:27Z","timestamp":1674018687000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00436-022-07753-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["7753"],"URL":"https:\/\/doi.org\/10.1007\/s00436-022-07753-8","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,13]]},"assertion":[{"value":"12 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval was obtained from the University of Ibadan\/University College Hospital Institutional Review Board (UI\/UCH\/IRB).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all parents\/guardians before enrollment into the study. Participants were free to withdraw if they felt otherwise to continue with the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Details of participants were not disclosed in the manuscript. Therefore, it can be published.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}